Breast cancer prevention study: are healthy women put at risk by federally funded research? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, October 22, 1992
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
aaouao adjuvant advisory BCPT blood Breast Cancer Action breast cancer prevention Cancer Prevention Trial centers clinical trials concerns developing breast cancer disease drug effects of tamoxifen endometrial endometrial cancer estrogen Fainberg Greenwald healthy women Healy high risk informed consent informed consent form liver cancer menopausal minority women model informed consent National Cancer Institute NSABP Oncology osteoporosis Participant's participate patients Payne percent placebo postmenopausal postmenopausal women potential premenopausal women prevent breast cancer prevention study protocol receiving tamoxifen reported risk of breast risks and benefits side effects subcommittee taking tamoxifen tamoxifen study tamoxifen trial toxicity treatment uaaq uterine cancer woman аге аз ап апа апй Гог оГ Ье оп опе пе пзк рив сапсег тау тоге ТЬе Ьа Ьауе Ьгеаз Ье Ьееп Ьу